Asian countries are well-positioned to benefit from the latest setback for stem cell research in the U.S. During the Bush years, countries such as Singapore and China took advantage of...
More news about Chinese doctors pushing the envelope by providing experimental treatment not available in the U.S. I recently wrote a BusinessWeek story about a drug made by a Chinese...
Bloomberg Businessweek’s team of Asia reporters brings you the latest insights on business, politics, technology and culture from some of the world’s biggest and fastest-growing economies.